Biopsy Device Market

Biopsy Device Market: Needles Product Type Segment Anticipated to Retain Its Dominance Throughout the Forecast Period: Global Industry Analysis and Opportunity Assessment, 2016-2026

Government initiatives in cancer treatment to fuel growth of the global biopsy device market during the projected period

Global demand for biopsy devices is increasing, supported by rising incidence of cancer. Future Market Insights presents in-depth analysis of the global biopsy device market for the forecast period, 2016–2026. Revenue from the global biopsy device market is expected to register a CAGR of 6.5% during the assessment period and is expected to be valued at nearly US$ 2,700 Mn by 2026 end. 

Increasing incidence of cancer and favourable reimbursement programs are factors expected to drive revenue growth of the global biopsy device market during the assessment period 

The guidance system segment was estimated to account for 16.1% revenue share of the global biopsy device market by 2016 end and is expected to gain 222 BPS in market share by 2026 over 2016, owing to an increase in the awareness of early detection of breast cancer.

The needles segment was estimated to account for 37.6% revenue share of the global biopsy device market by 2016 end and is expected to lose 125 BPS in market share by 2026 over 2016. The segment is expected to reach nearly US$ 960 Mn by 2026 owing to an increasing awareness among people regarding the early detection of cancer.

Global Biopsy Device Market Absolute $ Opportunity by Product Type, 2016–2026

  • Guidance system segment is estimated to create absolute $ opportunity of more than US$ 15 Mn in 2017 over 2016. Revenue from guidance system segment is anticipated to register a CAGR of 7.9% over 2016–2026, to reach more than US$ 480 Mn towards the close of the forecast period

  • Biopsy needles segment is estimated to create absolute $ opportunity of nearly US$ 30 Mn in 2017 over 2016. Revenue from biopsy needles segment is anticipated to register a CAGR of 6.2% over 2016–2026, to reach nearly US$ 960 Mn by 2026 end

  • Guns segment is estimated to create absolute $ opportunity of nearly US$ 25 Mn in 2017 over 2016. Revenue from guns segment is anticipated to witness a CAGR of 6.8% over 2016–2026, to reach more than US$ 700 Mn towards the close of 2026

  • Reagents and kits segment is estimated to create absolute $ opportunity of more than US$ 3 Mn in 2017 over 2016. Revenue from reagents and kits segment is anticipated to witness a CAGR of 6.4% over 2016–2026, to reach nearly US$ 120 Mn at the end of the assessment period

  • Others (Brushes, Curettes and Punches etc.) segment is estimated to create absolute $ opportunity of nearly US$ 10 Mn in 2017 over 2016. Revenue from Others segment is anticipated to witness a CAGR of 5.3% over 2016–2026, to reach more than US$ 360 Mn by 2026 end

Global Biopsy Device Market Attractiveness Analysis by Product Type, 2016–2026

Needles segment dominated the global biopsy device market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period. Needles segment is the most attractive segment, with a market attractiveness index of 1.8 over the forecast period. The segment accounted for 37.7% value share in 2016 and is projected to account for 36.5% share by 2026 end. Guns segment is expected to be the second most lucrative segment in the global biopsy device market, with a market attractiveness index of 1.3 during the forecast period. The increasing requirement for more advanced and innovative technology products in the field of biopsy and growing usage of biopsy needles makes it the most attractive segment in the global biopsy device market.                     

biopsy device market

Companies operating in the global biopsy device market are actively engaged in mergers, acquisitions and partnerships to capture a larger share of the market in the near future

The global biopsy device market is a fragmented market with about 69% market share contributed by CR Bard, Becton, Dickinson and Company, B. Braun Melsungen AG, Hologic, Inc., Cook Medical, Devicor Medical Products Inc. and Argon Medical Inc. Companies are entering into strategic mergers and acquisitions to improve their biopsy device product portfolio and are focussing on distributional agreements to overcome issues related to product availability in various geographical areas.

Analyst Viewpoint

“In the coming decade, liquid biopsy procedure is likely to pose a major threat to the biopsy device market”

Liquid biopsy offers non-invasive diagnostic tests for detecting cancer as it provides a simple, relatively less expensive blood, urine or plasma test to detect malignancy in any part of the patient’s body. Liquid biopsy is expected to provide a better sample for any type of diagnosis and analysis as it can be taken repeatedly. This overcomes the challenge associated with repeated tissue samples. Liquid samples help detect disease progression in real time, predict outcomes and switch treatment when required and potentially increase the life expectancy of the patient. Thus, liquid biopsy procedure is likely to be a major threat to the global biopsy device market in the coming decade.

Future Market Insights offers a one of its kind and a comprehensive analysis of the global biopsy device market in its new publication titled ‘Biopsy Device Market: Global Industry Analysis and Opportunity Assessment, 2016–2026’. In this report, Future Market Insights has focussed on offering detailed insights and in-depth research on the global biopsy device market over a ten year forecast period 2016 – 2026. In this report, we have covered the important factors driving the growth of the global biopsy device market, untapped opportunities for market players in this field, trends and developments shaping the dynamics of the global biopsy device market and other insights across various key segments. In addition, we have identified the key drivers and restraints affecting the growth of the global biopsy device market. Changing trends are also analysed and incorporated in the report to equip clients with exhaustive information about the market resulting in better decision making. Macroeconomic factors that directly and indirectly affect the growth of the global biopsy device market are also incorporated in the report.

Report Description

The primary objective of the report is to offer insights on the market dynamics that can influence revenue growth of the global biopsy device market over the forecast period. Insights on key trends, drivers, restraints, value forecasts and opportunities for companies in the global biopsy device market are presented in the report. To understand and assess opportunities in this market, the report offers market forecast on the basis of segmentation into product, application, end use and regions. The report provides global biopsy device market analysis in terms of market value (US$ Mn).

Market Segmentation

By Product Type

By Application

By End Use

By Region

  • Guidance System

    • Stereotactic X-Ray Guided Biopsy

    • Ultrasound Guided Biopsy

    • MRI Guided Biopsy

  • Needles

    • Core Needles

    • Fine Aspiration Needles

  • Guns

  • Reagents and Kits

  • Others (Brushes, Curettes and Punches etc.)

  • Medical Diagnosis

  • Scientific Research

 

  • Hospital

  • Specialised Oncology Centres

  • Diagnostic Centres

  • Research Institutes

 

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APEJ

  • Japan

  •  MEA

The report begins with the market definition, followed by definitions of the different biopsy device product types. The market dynamics section includes Future Market Insights’ analysis on key trends, drivers, restraints, opportunities and macro-economic factors influencing the growth of the global biopsy device market.

In the final section of the report, Future Market Insights has included a competitive landscape to provide clients with a dashboard view, based on categories of providers in the value chain, presence in the biopsy device market portfolio and key differentiators. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the biopsy device market value chain and the potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and success in the marketplace. Detailed profiles of providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings and recent developments in the global biopsy device market. In addition, this section also includes market strategies and SWOT analysis of the main players dominating the global biopsy device market.

Research Methodology

Forecasting the market numbers

Market value is inferred through in-depth secondary research and validated from industry experts through primary interviews. Each interview is thoroughly analysed and the average market value is deduced and reconfirmed prior to incorporating in the report. Weighted Average Selling Price (ASP) has been considered to deduce market values. Bottom-up approach has been used to assess market numbers for the global biopsy device market. Top-down approach has been used to counter-validate the reached numbers for the global biopsy device market. Macroeconomic indicators such as healthcare industry outlook, healthcare spending, prevalence of cancer, Gross Domestic Product and others have been considered to arrive at the indicated market numbers.

The forecast presented here assesses the total revenue by value across the market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the global biopsy device market will develop in the future. Given the characteristics of the market, we triangulated the outcome of different types of analyses based on the technology trends.

Key metrics

It is imperative to note that in an ever-fluctuating global economy, we not only conduct forecasts in terms of CAGR, but also analyse the market on the basis of key parameters such as year-on-year (Y-o-Y) growth to understand the predictability of the market and to identify the right opportunities across the market. As previously highlighted, the global biopsy device market is split into a number of segments. All segments in terms of by product type, by application, by end use and based on different regions are analysed in terms of basis point share to understand individual segments’ relative contribution to market growth. This detailed level of information is important for identification of various key trends of the global biopsy device market.

Also, another key feature of this report is the analysis of all key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical in assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective in the global biopsy device market. Last but not the least, in order to understand the key market segments in terms of growth and performance of the global biopsy device market, we have developed a one of its kind market attractiveness index. This index will be a great helping hand in enabling clients to identify real market opportunities.

Table Of Content

1.  Executive Summary

2.  Market Introduction

2.1. Market Definition

2.2. Market Taxonomy

2.3. Parent / Associated Market Overview

3.  Global Biopsy Device Analysis Scenario

3.1. Pricing Analysis

3.1.1. Pricing Assumptions

3.1.2. Price Projections Per Region

3.2. Market Size (US$ Mn) and Forecast

3.2.1. Market Size and Y-o-Y Growth

3.2.2. Absolute $ Opportunity

3.3. Market Overview

3.3.1. Value Chain

4.  Market Dynamics

4.1. Macro-economic Factors

4.2. Drivers

4.2.1. Supply Side

4.2.2. Demand Side

4.3. Restraints

4.4. Opportunity

4.5. Forecast Factors – Relevance and Impact

4.6. Global Incidence of Cancer

4.7. Global Trends

5. Global Biopsy Device Analysis and Forecasts, By Product 

5.1. Introduction

5.2. Basis Point Share (BPS) Analysis By Product Type

5.3. Y-o-Y Growth Projections By Product Type

5.4. Market Value and Volume Forecast By Product, 2016–2026

5.4.1. Guidance System

5.4.1.1. Stereotactic X-Ray Guided Biopsy

5.4.1.2. Ultrasound Guided Biopsy

5.4.1.3. MRI Guided Biopsy

5.4.2. Needles

5.4.2.1. Core Needle

5.4.2.2. Fine Aspiration Needles

5.4.3. Guns

5.4.4. Reagents and Kits

5.4.5. Others (Brushes, Curettes and Punches etc.)

5.5. Market Attractiveness By Product 

6. Global Biopsy Device Analysis and Forecasts, By Application 

6.1. Introduction

6.2. Basis Point Share (BPS) Analysis By Application 

6.3. Y-o-Y Growth Projections By Application 

6.4. Market Value Forecast By Application, 2016–2026

6.4.1. Scientific Research

6.4.2. Medical Diagnostics

6.5. Market Attractiveness By Application 

7. Global Biopsy Device Analysis and Forecasts, By End Users 

7.1. Introduction

7.2. Basis Point Share (BPS) Analysis By End Users 

7.3. Y-o-Y Growth Projections By End Users 

7.4. Market Value Forecast By End Users, 2016–2026

7.4.1. Hospitals

7.4.2. Specialized Oncology Centers

7.4.3. Diagnostic Centers

7.4.4. Research Institutes

7.5. Market Attractiveness By End Users 

8. Global Biopsy Device Analysis and Forecasts, By Region

8.1. Basis Point Share (BPS) Analysis By Region

8.2. Y-o-Y Growth Projections By Region

8.3. Market Value Forecast By Region

8.3.1. North America 

8.3.2. Latin America 

8.3.3. Western Europe 

8.3.4. Eastern Europe 

8.3.5. APEJ 

8.3.6. Japan 

8.3.7. MEA 

8.4. Market Attractiveness By Region

9. North America Biopsy Device Analysis and Forecast

9.1. Introduction

9.1.1. Basis Point Share (BPS) Analysis By Country

9.1.2. Y-o-Y Growth Projections By Country

9.1.3. Key Regulations

9.2. Market Value and Volume Forecast By Product, 2016–2026

9.2.1. Guidance System

9.2.1.1. Stereotactic X-Ray Guided Biopsy

9.2.1.2. Ultrasound Guided Biopsy

9.2.1.3. MRI Guided Biopsy

9.2.2. Needles

9.2.2.1. Core Needle

9.2.2.2. Fine Aspiration Needles

9.2.3. Guns

9.2.4. Reagents and Kits

9.2.5. Others (Brushes, Curettes and Punches etc.)

9.3. Market Value Forecast By Application, 2016–2026

9.3.1. Scientific Research

9.3.2. Medical Diagnostics

9.4. Market Value Forecast By End Users, 2016–2026

9.4.1. Hospitals

9.4.2. Specialized Oncology Centers

9.4.3. Diagnostic Centers

9.4.4. Research Institutes

9.5. Market Value Forecast By Country, 2016–2026

9.5.1. US

9.5.2. Canada

9.6. Market Attractiveness Analysis 

9.6.1. By Product 

9.6.2. By Application 

9.6.3. By End Users 

9.6.4. By Country

10. Latin America Biopsy Device Analysis and Forecast

10.1.Introduction

10.1.1. Basis Point Share (BPS) Analysis By Country

10.1.2. Y-o-Y Growth Projections By Country

10.1.3. Key Regulations

10.2.Market Value and Volume Forecast By Product, 2016–2026

10.2.1. Guidance System

10.2.1.1. Stereotactic X-Ray Guided Biopsy

10.2.1.2. Ultrasound Guided Biopsy

10.2.1.3. MRI Guided Biopsy

10.2.2. Needles

10.2.2.1. Core Needle

10.2.2.2. Fine Aspiration Needles

10.2.3. Guns

10.2.4. Reagents and Kits

10.2.5. Others (Brushes, Curettes and Punches etc.)

10.3.Market Value Forecast By Application, 2016–2026

10.3.1. Scientific Research

10.3.2. Medical Diagnostics

10.4.Market Value Forecast By End Users, 2016–2026

10.4.1. Hospitals

10.4.2. Specialized Oncology Centers

10.4.3. Diagnostic Centers

10.4.4. Research Institutes

10.5.Market Value Forecast By Country, 2016–2026

10.5.1. Argentina

10.5.2. Brazil

10.5.3. Mexico

10.5.4. Rest of Latin America

10.6.Market Attractiveness Analysis 

10.6.1. By Product 

10.6.2. By Application 

10.6.3. By End Users 

10.6.4. By Country

11. Western Europe Biopsy Device Analysis and Forecast

11.1.Introduction

11.1.1. Basis Point Share (BPS) Analysis By Country

11.1.2. Y-o-Y Growth Projections By Country

11.1.3. Key Regulations

11.2.Market Value and Volume Forecast By Product, 2016–2026

11.2.1. Guidance System

11.2.1.1. Stereotactic X-Ray Guided Biopsy

11.2.1.2. Ultrasound Guided Biopsy

11.2.1.3. MRI Guided Biopsy

11.2.2. Needles

11.2.2.1. Core Needle

11.2.2.2. Fine Aspiration Needles

11.2.3. Guns

11.2.4. Reagents and Kits

11.2.5. Others (Brushes, Curettes and Punches etc.)

11.3.Market Value Forecast By Application, 2016–2026

11.3.1. Scientific Research

11.3.2. Medical Diagnostics

11.4.Market Value Forecast By End Users, 2016–2026

11.4.1. Hospitals

11.4.2. Specialized Oncology Centers

11.4.3. Diagnostic Centers

11.4.4. Research Institutes

11.5.Market Value Forecast By Country, 2016–2026

11.5.1. UK

11.5.2. France

11.5.3. Germany

11.5.4. Italy

11.5.5. Spain

11.5.6. Nordic

11.5.7. Benelux

11.5.8. Rest of Western Europe

11.6.Market Attractiveness Analysis 

11.6.1. By Product 

11.6.2. By Application 

11.6.3. By End Users 

11.6.4. By Country

12. Eastern Europe Biopsy Device Analysis and Forecast

12.1.Introduction

12.1.1. Basis Point Share (BPS) Analysis By Country

12.1.2. Y-o-Y Growth Projections By Country

12.1.3. Key Regulations

12.2.Market Value and Volume Forecast By Product, 2016–2026

12.2.1. Guidance System

12.2.1.1. Stereotactic X-Ray Guided Biopsy

12.2.1.2. Ultrasound Guided Biopsy

12.2.1.3. MRI Guided Biopsy

12.2.2. Needles

12.2.2.1. Core Needle

12.2.2.2. Fine Aspiration Needles

12.2.3. Guns

12.2.4. Reagents and Kits

12.2.5. Others (Brushes, Curettes and Punches etc.)

12.3.Market Value Forecast By Application, 2016–2026

12.3.1. Scientific Research

12.3.2. Medical Diagnostics

12.4.Market Value Forecast By End Users, 2016–2026

12.4.1. Hospitals

12.4.2. Specialized Oncology Centers

12.4.3. Diagnostic Centers

12.4.4. Research Institutes

12.5.Market Value Forecast By Country, 2016–2026

12.5.1. Russia

12.5.2. Poland

12.5.3. Rest of Eastern Europe

12.6.Market Attractiveness Analysis 

12.6.1. By Product 

12.6.2. By Application 

12.6.3. By End Users 

12.6.4. By Country

13. APEJ Biopsy Device Analysis and Forecast

13.1.Introduction

13.1.1. Basis Point Share (BPS) Analysis By Country

13.1.2. Y-o-Y Growth Projections By Country

13.1.3. Key Regulations

13.2.Market Value and Volume Forecast By Product, 2016–2026

13.2.1. Guidance System

13.2.1.1. Stereotactic X-Ray Guided Biopsy

13.2.1.2. Ultrasound Guided Biopsy

13.2.1.3. MRI Guided Biopsy

13.2.2. Needles

13.2.2.1. Core Needle

13.2.2.2. Fine Aspiration Needles

13.2.3. Guns

13.2.4. Reagents and Kits

13.2.5. Others (Brushes, Curettes and Punches etc.)

13.3.Market Value Forecast By Application, 2016–2026

13.3.1. Scientific Research

13.3.2. Medical Diagnostics

13.4.Market Value Forecast By End Users, 2016–2026

13.4.1. Hospitals

13.4.2. Specialized Oncology Centers

13.4.3. Diagnostic Centers

13.4.4. Research Institutes

13.5.Market Value Forecast By Country, 2016–2026

13.5.1. China

13.5.2. India

13.5.3. Australia & New Zealand

13.5.4. ASEAN

13.5.5. Rest of APEJ

13.6.Market Attractiveness Analysis 

13.6.1. By Product 

13.6.2. By Application 

13.6.3. By End Users 

13.6.4. By Country

14. Japan Biopsy Device Analysis and Forecast

14.1.Introduction

14.1.1. Basis Point Share (BPS) Analysis By Country

14.1.2. Y-o-Y Growth Projections By Country

14.1.3. Key Regulations

14.2.Market Value and Volume Forecast By Product, 2016–2026

14.2.1. Guidance System

14.2.1.1. Stereotactic X-Ray Guided Biopsy

14.2.1.2. Ultrasound Guided Biopsy

14.2.1.3. MRI Guided Biopsy

14.2.2. Needles

14.2.2.1. Core Needle

14.2.2.2. Fine Aspiration Needles

14.2.3. Guns

14.2.4. Reagents and Kits

14.2.5. Others (Brushes, Curettes and Punches etc.)

14.3.Market Value Forecast By Application, 2016–2026

14.3.1. Scientific Research

14.3.2. Medical Diagnostics

14.4.Market Value Forecast By End Users, 2016–2026

14.4.1. Hospitals

14.4.2. Specialized Oncology Centers

14.4.3. Diagnostic Centers

14.4.4. Research Institutes

14.5.Market Attractiveness Analysis 

14.5.1. By Product 

14.5.2. By Application 

14.5.3. By End Users 

15. MEA Biopsy Device Analysis and Forecast

15.1.Introduction

15.1.1. Basis Point Share (BPS) Analysis By Country

15.1.2. Y-o-Y Growth Projections By Country

15.1.3. Key Regulations

15.2.Market Value and Volume Forecast By Product, 2016–2026

15.2.1. Guidance System

15.2.1.1. Stereotactic X-Ray Guided Biopsy

15.2.1.2. Ultrasound Guided Biopsy

15.2.1.3. MRI Guided Biopsy

15.2.2. Needles

15.2.2.1. Core Needle

15.2.2.2. Fine Aspiration Needles

15.2.3. Guns

15.2.4. Reagents and Kits

15.2.5. Others (Brushes, Curettes and Punches etc.)

15.3.Market Value Forecast By Application, 2016–2026

15.3.1. Scientific Research

15.3.2. Medical Diagnostics

15.4.Market Value Forecast By End Users, 2016–2026

15.4.1. Hospitals

15.4.2. Specialized Oncology Centers

15.4.3. Diagnostic Centers

15.4.4. Research Institutes

15.5.Market Value Forecast By Country, 2016–2026

15.5.1. GCC Countries

15.5.2. South Africa

15.5.3. North Africa

15.5.4. Rest of MEA

15.6.Market Attractiveness Analysis 

15.6.1. By Product 

15.6.2. By Application 

15.6.3. By End Users 

15.6.4. By Country

16. Competition Landscape

16.1. Competition Dashboard

16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)

16.2.1. Becton, Dickinson and Company 

16.2.2. Argon Medical Inc. 

16.2.3. B. Braun Melsungen AG 

16.2.4. Boston Scientific Inc. 

16.2.5. C. R. Bard, Inc. 

16.2.6. Hologic, Inc. 

16.2.7. Cook Medical 

16.2.8. INRAD Inc. 

16.2.9. Devicor Medical Products Inc. 

16.2.10. PLANMED OY

17. Assumptions and Acronyms Used

18. Research Methodology

List of Tables

Table 01: Global Biopsy Device Market, Global Incidence of Cancer, 2012 

Table 02: Global Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 03: Global Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 04: Global Biopsy Device Volume, By Product Type, 2016 - 2026

Table 05: Global Biopsy Device Market Value, By Application, 2016 - 2026

Table 06: Global Biopsy Device Market Value, By End Users, 2016 - 2026

Table 07: Global Biopsy Device Market Value, By Region, 2016 - 2026

Table 08: North America Biopsy Device Market Value, By Country, 2016 - 2026

Table 09: North America Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 10: North America Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 11: North America Biopsy Device Volume, By Product Type, 2016 - 2026

Table 12: North America Biopsy Device Market Value, By Application, 2016 - 2026

Table 13: North America Biopsy Device Market Value, By End Users, 2016 - 2026

Table 14: Latin America Biopsy Device Market Value (%) By Country, 2016 - 2026

Table 15: Latin America Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 16: Latin America Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 17: Latin America Biopsy Device Volume, By Product Type, 2016 - 2026

Table 18: Latin America Biopsy Device Market Value, By Application, 2016 - 2026

Table 19: Latin America Biopsy Device Market Value, By End Users, 2016 - 2026

Table 20: Western Europe Biopsy Device Market Value By Country, 2016 - 2026

Table 21: Western Europe Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 22: Western Europe Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 23: Western Europe Biopsy Device Volume, By Product Type, 2016 - 2026

Table 24: Western Europe Biopsy Device Market Value, By Application, 2016 - 2026

Table 25: Western Europe Biopsy Device Market Value, By End Users, 2016 - 2026

Table 26: Western Europe Biopsy Device Market Value, By Country, 2016 - 2026

Table 27: Eastern Europe Biopsy Device Market Value, By Country, 2016 - 2026

Table 28: Eastern Europe Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 29: Eastern Europe Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 30: Eastern Europe Biopsy Device Volume, By Product Type, 2016 - 2026

Table 31: Eastern Europe Biopsy Device Market Value, By Application, 2016 - 2026

Table 32: Eastern Europe Biopsy Device Market Value, By End Users, 2016 - 2026

Table 33: APEJ Biopsy Device Market Value, By Country, 2016 - 2026

Table 34: APEJ Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 35: APEJ Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 36: APEJ Biopsy Device Volume, By Product Type, 2016 - 2026

Table 37: APEJ Biopsy Device Market Value, By Application, 2016 - 2026

Table 38: APEJ Biopsy Device Market Value, By End Users, 2016 - 2026

Table 39: Japan Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 40: Japan Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 41: Japan Biopsy Device Volume, By Product Type, 2016 - 2026

Table 42: Japan Biopsy Device Market Value, By Application, 2016 - 2026

Table 43: Japan Biopsy Device Market Value, By End Users, 2016 - 2026

Table 44: MEA Biopsy Device Market Value, By Country, 2016 - 2026

Table 45: MEA Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 46: MEA Biopsy Device Market Value, By Product Type, 2016 - 2026

Table 47: Japan Biopsy Device Volume, By Product Type, 2016 - 2026

Table 48: MEA Biopsy Device Market Value By Application, 2016 - 2026

Table 49: MEA Biopsy Device Market Value By End Users, 2016 - 2026

List of Figures

Figure 1: Biopsy Device Market Share, by Application Type, 2016 (E)

Figure 2: Biopsy Device Market Share, by Product Type, 2016 (E)

Figure 3: Biopsy Device Market Share, by End User, 2016 (E)

Figure 4:  Global Guidance System, Price Difference (US$) By Region, 2015

Figure 5: Global Guidance System, Price Difference (US$) By Region, 2026

Figure 6:  Global Biopsy Needles, Price Difference (US$) By Region, 2015

Figure 7:  Global Biopsy Needles, Price Difference (US$) By Region, 2026

Figure 8:  Global Biopsy Guns, Price Difference (US$) By Region, 2015

Figure 9:  Global Biopsy Guns, Price Difference (US$) By Region, 2026

Figure 10:  Global Others, Price Difference (US$) By Region, 2015

Figure 11:  Global Others, Price Difference (US$) By Region, 2026

Figure 12:  Global Biopsy Kits and Reagents, Price Difference (US$) By Region, 2015

Figure 13:  Global Biopsy Kits and Reagents, Price Difference (US$) By Region, 2026

Figure 14: Global Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 15: Global Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 16: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 17: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 18: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 19: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 20: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 21: Global Biopsy Device Market Attractiveness Analysis by Product Type, 2016–2026

Figure 22: Global Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 23: Global Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 24: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 25: Global Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 26: Global Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

 Figure 27: Global Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 28: Global Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 29: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 30: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 31: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 32: Global Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 33: Global Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

 Figure 34: Global Biopsy Device Market Share Analysis (%) By Region, 2016 & 2026

Figure 35: Global Biopsy Device Y-o-Y growth (%) By Region 2015–2026

Figure 36: Global Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

 Figure 37: North America Biopsy Device Market Share Analysis (%) By Country, 2016 & 2026

Figure 38: North America Biopsy Device Y-o-Y growth (%) By Country 2015–2026

Figure 39: North America Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 40: North America Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 41: North America Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 42: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 43: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 44: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 45: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 46: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 47: North America Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 48: North America Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 49: North America Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 50: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 51: North America Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 52: North America Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 53: North America Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 54: North America Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 55: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 56: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 57: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic Centers Segment, 2016–2026

Figure 58: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 59: North America Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

 Figure 60: Latin America Biopsy Device Market Share Analysis (%) By Country, 2016 & 2026

Figure 61: Latin America Biopsy Device Y-o-Y growth (%) By Country 2015–2026

Figure 62: Latin America Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 63: Latin America Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 64: Latin America Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 65: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 66: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 67: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 68: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 69: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 70: Latin America Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 71: Latin America Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 72: Latin America Biopsy Device Y-o-Y growth (%) By Application, 2015–2026z

Figure 73: North America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 74: North America Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 75: Latin America Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 76: Latin America Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 77: Latin America Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 78: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 79: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 80: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 81: Latin America Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 82: Latin America Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure 83: Western Europe  Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 84: Western Europe  Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 85: Western Europe  Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 86: Western Europe Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 87: Western Europe Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 88: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 89: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 90: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 91: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 92: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 93: Western Europe Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 94: Western Europe Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 95: Western Europe Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 96: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 97: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 98: Western Europe Biopsy Device Market Attractiveness Analysis by Application, 2016–2026

Figure 99: Western Europe Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 100: Western Europe Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 101: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 102: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 103: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 104: Western Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 105: Western Europe Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure 106: Eastern Europe Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 107: Eastern Europe  Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 108: Eastern Europe Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 109: Eastern Europe Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 110: Eastern Europe Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 111: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 112: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 113: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guns Segment, 2016–2026

Figure 114: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Reagents and Kits Segment, 2016–2026

Figure 115: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 116: Eastern Europe Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 117: Eastern Europe Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 118: Eastern Europe Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 119: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 120: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 121: Eastern Europe Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 122: Eastern Europe Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 123: Eastern Europe Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 124: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 125: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 126: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 127: Eastern Europe Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 128: Eastern Europe Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure 129: APEJ Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 130: APEJ Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 131: APEJ Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 132: APEJ Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 133: APEJ Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 134: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 135: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 136: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By guns Segment, 2016–2026

Figure 137: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By reagents and kits Segment, 2016–2026

Figure 138: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 139: APEJ Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 140: APEJ Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 141: APEJ Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 142: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 143: APEJ Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 144: APEJ Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 145: APEJ Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 146: APEJ Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 147: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 148: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 149: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 150: APEJ Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 151: APEJ Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure  152: Japan Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 153: Japan Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 154: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 155: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 156: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By guns Segment, 2016–2026

Figure 157: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By reagents and kits Segment, 2016–2026

Figure 158: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 159: Japan Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 160: Japan Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 161: Japan Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 162: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 163: Japan Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 164: Japan Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 165: Japan Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 166: Japan Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 167: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 168: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 169: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 170: Japan Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 171: Japan Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026

Figure 172: MEA Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 173: MEA Biopsy Device Y-o-Y growth (%) By Country, 2015–2026

Figure 174: MEA Biopsy Device Market Attractiveness Analysis By Country, 2016–2026

Figure 175: MEA Biopsy Device Market Share Analysis (%) By Product Type, 2016 & 2026

Figure 176: MEA Biopsy Device Y-o-Y growth (%) By Product Type, 2015–2026

Figure 177: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Guidance System Segment, 2016–2026

Figure 178: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Biopsy Needles Segment, 2016–2026

Figure 179: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By guns Segment, 2016–2026

Figure 180: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By reagents and kits Segment, 2016–2026

Figure 181: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Others Segment, 2016–2026

Figure 182: MEA Biopsy Device Market Attractiveness Analysis By Product Type, 2016–2026

Figure 183: MEA Biopsy Device Market Share Analysis (%) By Application, 2016 & 2026

Figure 184: MEA Biopsy Device Y-o-Y growth (%) By Application, 2015–2026

Figure 185: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Medical Diagnostic Segment, 2016–2026

Figure 186: MEA Biopsy Device Market Absolute $  Opportunity (US$ Mn) By Scientific Research Segment, 2016–2026

Figure 187: MEA Biopsy Device Market Attractiveness Analysis By Application, 2016–2026

Figure 188: MEA Biopsy Device Market Share Analysis (%) By End Users, 2016 & 2026

Figure 189: MEA Biopsy Device Y-o-Y growth (%) By End Users, 2015–2026

Figure 190: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Hospital Segment, 2016–2026

Figure 191: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Specialized Oncology Center Segment, 2016–2026

Figure 192: MEA Biopsy Device Market Absolute $ Opportunity (US$ Mn) By Diagnostic centers Segment, 2016–2026

Figure 193: MEA Biopsy Device Market Attractiveness Analysis By End Users, 2016–2026